Friday, September 10, 2010

Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.

If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines


Get up-to-the-minute Globe Business Updates   |  More Business News
 
ADVERTISEMENT

Globe Today

Friday, September 10, 2010

Genzyme plans to cut 1,000 jobs
Employees at Genzyme Corp. sites around the world are being notified in the coming days about planned staffing reductions at the Cambridge-based biotechnology company.

Boston is tops in innovation, survey says
Boston is rated as the most innovative city in the global economy, according to a survey by an Austalian consulting firm.

Femmes fatales have locals calling Yahoo!
Women topped the list of fast-spiking Yahoo.com searches last week.

Turbine makes Lord of the Rings Online free to play
An online video game based on the fantasy novels of J.R.R. Tolkien can now be played free of charge.

Chamber announces small business awards
Sagamore Plumbing & Heating is the Greater Boston Chamber of Commerce "?Small Business of the Year," the chamber said today.

Kitchen nightmares abound in the Hub
Parents in Boston are more likely to describe themselves as "kitchen nightmares" than parents in any other part of the country.

RI tax revenues up by more than 11 percent
Rhode Island tax revenues were up more than 11 percent in the two-month period that ended Aug. 31 when compared to the same period last year, numbers some say could be a sign of an economic turnaround.

Good Start Genetics raises $18m
Good Start Genetics Inc.announced the completion of an $18 million Series A financing and said that Don Hardison has been appointed president and chief executive.

Today in Globe Business
A sample of Business stories from today's Globe.

Thursday, September 9, 2010

Harvard endowment climbs 11% but underperforms market
Harvard University's endowment climbed 11 percent for the year ending June 30 but underperforming other large funds and the stock market.

Sanofi-Aventis sticking to first offer for Genzyme
French drugmaker Sanofi-Aventis SA says it's sticking to its original offer of $69 per share to buy Cambridge biotechnology company Genzyme Corp.

No comments:

Post a Comment